HASSAN, M.; MERZA, N.; NAWRAS, Y.; ALFATLAWI, H.; AL OBAIDI, hasan; SAAB, O.; AL ZUBAIDI, K.; AL-SABBAGH, D.; MANSUR, S.; ALGODI, M.; AL NAJAFI, O.; MATBACHI, R.; AL HAMDANY, T.; NOORI, Z.; KOBEISSY, A. Effect of Pemafibrate, a Selective Peroxisome Proliferator-activated Receptor ? Modulator (SPPARM?), on the Lipid Profile, Liver Function, and Liver Fibrosis among Patients with Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. Translation: The University of Toledo Journal of Medical Sciences, [S. l.], v. 13, n. S3, 2025. DOI: 10.46570/utjms-2025-1397. Disponível em: https://openjournals.utoledo.edu/index.php/translation/article/view/1397. Acesso em: 1 jul. 2025.